This site is currently not optimized for mobile devices. For the best user experience, please access the site via a device with a wider screen such as a desktop or laptop.

For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Once enabled, click here to view the site.

signup link button why should I sign up?
Login as Volunteer Login as Study team member
OR

Studies researching your condition/s 9

Based on the information you provided, you may be eligible for the following studies researching your condition/s.

  • A First-In-Human Study of Dosing with REGN2810 as Single Therapy and in Combination with Other Anti-Cancer Therapies in Patients with Advanced Malignancies Study purpose: find safe dose of REGN2810 given alone or in combination therapies;measure levels of REGN2810 in blood; evaluate if REGN2810 given alone or in combination w/other therapies will cause tumor shrinkage;test different dose levels of REGN2810, radiotherapy, GM-CSF, and cyclophosphamide. This study is researching all of the following topics: Bladder cancer Breast cancer Cervical cancer Colorectal / Colon / Rectal cancer Esophagus cancer HCC, Liver cancer Kidney Cancer ( Malignant tumor of kidney ) Laryngeal cancer, Cancer of the larynx, Voice box cancer Lung cancer Oral / Mouth cancer Ovarian cancer Pancreatic cancer Prostate cancer Stomach cancer, Gastric cancer ( Malignant tumor of stomach ) Thyroid cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Phase II study of ponatinib for advanced cancers with genomic alterations in fibroblastic growth factor receptor (FGFR) and other genomic targets (KIT, PDGFRa, RET FLT3, ABL1) The purpose of this study is to find out what effects; good and/or bad, ponatinib has on you and your cancer. Your body has proteins that are involved in a cancer’s ability to grow and survive. The drug, Ponatinib, may prevent these proteins from causing cancer growth. This study is researching all of the following topics: Bladder cancer Breast cancer Colon Cancer ( Malignant tumor of colon ) Colorectal / Colon / Rectal cancer Esophagus cancer Kidney Cancer ( Malignant tumor of kidney ) Lung cancer Ovarian cancer Pancreatic cancer Prostate cancer Thyroid cancer Uterine / Uterus cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Phase 1, Open-label, Dose Escalation, Safety and Tolerability Study of Investigational Drug INCB054828 in Subjects with Advanced Malignancies Study goals: determine dose that is safe and tolerable in people with advanced cancer and select the doses that will be studied further; see how INCB054828 acts on and in the body; see effect INCB054828 has on the growth of your cancer; see action of INCB054828 in the body over a period of time This study is researching all of the following topics: Bladder cancer Cervical cancer Colon Cancer ( Malignant tumor of colon ) Colorectal / Colon / Rectal cancer Kidney Cancer ( Malignant tumor of kidney ) Lung cancer Multiple myeloma Prostate cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Ph III, Open-Label, Randomized Study of Atezolizumab (Anti-PD-L1 Antibody) Vs. Observation as Adjuvant Therapy in Patients w/ PD-L1-Selected, High-Risk Muscle-Invasive Bladder Cancer After Cystectomy The study purpose is to compare the effects, good or bad, of atezolizumab (also known as MPDL3280A) versus observation (not receiving any treatment) on you and your bladder cancer to find out which is better. Atezolizumab is an experimental drug.You will get either atezolizumab or no treatment. This study is researching all of the following topics: Bladder cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Phase II Trial of Palbociclib (PD-0332991) in Patients with Metastatic Urothelial Cancer (UC) after Failure of First-Line Chemotherapy Palbociclib is an experimental drug (not approved for treatment of urothelial cancer) that works by blocking the ability of a tumor¿s cells to grow and divide.The main purpose of this study is to see if the study drug, palbociclib, helps to slow the growth of your tumor. This study is researching all of the following topics: Bladder cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Survey of Cancer Survivors Treatment Preferences for Cancer-Related Fatigue The purpose of our study is to see how cancer patients and survivors would like to learn about acupressure or diet as a treatment for their cancer symptoms like fatigue as well as general information about technology used and their environment. This study is researching all of the following topics: Adrenal cancer BCC, Basal cell skin cancer Bile duct cancer Bladder cancer Bone cancer Brain cancer Breast cancer Cancerous bone tumor, Osteosarcoma Cervical cancer Colon Cancer ( Malignant tumor of colon ) Colorectal / Colon / Rectal cancer Esophagus cancer Fallopian tube cancer HCC, Liver cancer HNPCC, Lynch Syndrome ( Hereditary NonPolyposis Colorectal Cancer ) Kidney Cancer ( Malignant tumor of kidney ) Laryngeal cancer, Cancer of the larynx, Voice box cancer Lung cancer NPC, Nasal cancer Oral / Mouth cancer Ovarian cancer Pancreatic cancer PPC, Primary peritoneal cancer Prostate cancer Salivary Gland Cancer Skin Cancer ( Malignant neoplasm of skin ) Squamous cell skin cancer Thyroid cancer Uterine / Uterus cancer This study is looking for: male female both men and women Volunteers with specific conditions and Healthy volunteers
    • More than 18 years old
  • Open-Label Single-Arm Ph 2 Study of Mocetinostat in Selected Patients with Inactivating Alterations of Acetyltransferase Genes in Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma The main purpose of this study is to test whether patients with urothelial carcinoma with specific changes in the tumor genes benefit from treatment with investigational drug mocetinostat, assess side effects, and see how much and how quickly drug is absorbed and cleared from the blood stream. This study is researching all of the following topics: Bladder cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Phase I Study of the Safety and Pharmacokinetics of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects with Metastatic Urothelial Cancer that Express Nectin-4 The study purpose is to determine the highest, safe dose of the investigational drug ASG-22CE when given to subjects with metastatic urothelial cancer.The study will evaluate how much should be given to subjects, the side effects to cancer patients, the effects on your body, and on your cancer. This study is researching all of the following topics: Bladder cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Phase I safety study of intratumoral injection of Clostridium novyi-NT spores in patients with treatment-refractory solid tumor malignancies This study is being done to learn whether treatment with Clostridium novyi-NT spores (NT refers to non-toxin producing) is safe and effective in patients with advanced cancers that can no longer be controlled with standard therapy or cancers for which there is no standard effective treatment. This study is researching all of the following topics: Adrenal cancer BCC, Basal cell skin cancer Bladder cancer Bone cancer Breast cancer Cervical cancer Colon Cancer ( Malignant tumor of colon ) Esophagus cancer Fallopian tube cancer HCC, Liver cancer Kidney Cancer ( Malignant tumor of kidney ) Laryngeal cancer, Cancer of the larynx, Voice box cancer Lung cancer Lymphoma NPC, Nasal cancer Oral / Mouth cancer Ovarian cancer Pancreatic cancer Prostate cancer Salivary Gland Cancer Sarcoma Squamous cell skin cancer Thyroid cancer Uterine / Uterus cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old

Studies researching other conditions 78

You may also be eligible for the following studies researching other conditions, either as a volunteer with condition/s or as a healthy volunteer.